Meeder Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.2K | Hold |
5,363
| – | – | ﹤0.01% | 431 |
|
2025
Q1 | $26.1K | Hold |
5,363
| – | – | ﹤0.01% | 494 |
|
2024
Q4 | $51.3K | Hold |
5,363
| – | – | ﹤0.01% | 356 |
|
2024
Q3 | $44.8K | Sell |
5,363
-688
| -11% | -$5.75K | ﹤0.01% | 380 |
|
2024
Q2 | $41.3K | Buy |
+6,051
| New | +$41.3K | ﹤0.01% | 372 |
|
2023
Q1 | – | Sell |
-2,362
| Closed | -$27.9K | – | 677 |
|
2022
Q4 | $27.9K | Buy |
2,362
+395
| +20% | +$4.67K | ﹤0.01% | 582 |
|
2022
Q3 | $42K | Buy |
1,967
+1,884
| +2,270% | +$40.2K | ﹤0.01% | 895 |
|
2022
Q2 | $3K | Sell |
83
-1,033
| -93% | -$37.3K | ﹤0.01% | 1787 |
|
2022
Q1 | $46K | Buy |
+1,116
| New | +$46K | ﹤0.01% | 993 |
|
2021
Q4 | – | Sell |
-481
| Closed | -$24K | – | 1500 |
|
2021
Q3 | $24K | Sell |
481
-3,261
| -87% | -$163K | ﹤0.01% | 1352 |
|
2021
Q2 | $236K | Buy |
3,742
+566
| +18% | +$35.7K | 0.01% | 691 |
|
2021
Q1 | $295K | Buy |
3,176
+3,074
| +3,014% | +$286K | 0.02% | 635 |
|
2020
Q4 | $9K | Sell |
102
-4,434
| -98% | -$391K | ﹤0.01% | 1019 |
|
2020
Q3 | $469K | Sell |
4,536
-1,156
| -20% | -$120K | 0.03% | 372 |
|
2020
Q2 | $450K | Sell |
5,692
-283
| -5% | -$22.4K | 0.03% | 396 |
|
2020
Q1 | $346K | Buy |
5,975
+2,582
| +76% | +$150K | 0.03% | 430 |
|
2019
Q4 | $182K | Buy |
3,393
+2,340
| +222% | +$126K | 0.01% | 630 |
|
2019
Q3 | $55K | Sell |
1,053
-3,440
| -77% | -$180K | ﹤0.01% | 981 |
|
2019
Q2 | $216K | Sell |
4,493
-2,916
| -39% | -$140K | 0.02% | 560 |
|
2019
Q1 | $375K | Sell |
7,409
-2,196
| -23% | -$111K | 0.03% | 425 |
|
2018
Q4 | $570K | Sell |
9,605
-1,446
| -13% | -$85.8K | 0.05% | 302 |
|
2018
Q3 | $727K | Sell |
11,051
-6,725
| -38% | -$442K | 0.05% | 299 |
|
2018
Q2 | $898K | Buy |
17,776
+13,957
| +365% | +$705K | 0.08% | 229 |
|
2018
Q1 | $201K | Sell |
3,819
-2,322
| -38% | -$122K | 0.02% | 452 |
|
2017
Q4 | $285K | Buy |
6,141
+1,409
| +30% | +$65.4K | 0.02% | 422 |
|
2017
Q3 | $191K | Buy |
4,732
+2,302
| +95% | +$92.9K | 0.02% | 472 |
|
2017
Q2 | $83K | Buy |
2,430
+2,206
| +985% | +$75.3K | 0.01% | 595 |
|
2017
Q1 | $7K | Buy |
+224
| New | +$7K | ﹤0.01% | 948 |
|
2016
Q3 | – | Sell |
-19,056
| Closed | -$536K | – | 802 |
|
2016
Q2 | $536K | Buy |
19,056
+13,254
| +228% | +$373K | 0.05% | 399 |
|
2016
Q1 | $211K | Buy |
+5,802
| New | +$211K | 0.02% | 564 |
|
2015
Q2 | – | Sell |
-7,265
| Closed | -$209K | – | 488 |
|
2015
Q1 | $209K | Buy |
+7,265
| New | +$209K | 0.02% | 413 |
|